The time of cure: hepatitis C treatment and the matter of reinfection among people who inject drugs

References

• Australian Government Department of Health and Ageing. (2019). Fifth national hepatitis C strategy 2018-2022. Australian Government.
   Google Scholar
• Banerjee, D., & Reddy, K. R. (2016). Review article: safety and tolerability of direct-acting anti-viral agents in the new era of hepatitis C therapy. Alimentary Pharmacology & Therapeutics, 43(6), 674–696. https://doi.org/10.1111/apt.13514
   PubMed Web of Science ®Google Scholar
• Barad, K. (2015). Transmaterialities: Trans*/Matter/Realities and Queer Political Imaginings.
   Google Scholar
• Blogg, J., Wright, T., McGrath, C., & Clegg, J. (2020, Jan 15). Hepatitis C reinfection in prisons with broad access to direct acting antiviral treatments. The International Journal on Drug Policy, 77, 102597.
   PubMed Web of Science ®Google Scholar
• Carson, J. M., Barbieri, S., Matthews, G. V., Dore, G. J., & Hajarizadeh, B. (2023). National trends in retreatment of HCV due to reinfection or treatment failure in Australia. Journal of Hepatology, 78(2), 260–270. https://doi.org/10.1016/j.jhep.2022.09.011
   PubMed Web of Science ®Google Scholar
• Clark, J. A., & Gifford, A. L. (2015). Resolute efforts to cure hepatitis C: Understanding patients’ reasons for completing antiviral treatment. Health: An Interdisciplinary Journal for the Social Study of Health, Illness and Medicine, 19(5), 473–489. https://doi.org/10.1177/1363459314555237
   Google Scholar
• Cuevas-Hewitt, M. (2011). Towards a futurology of the present: Notes on writing, movement, and time. The Journal of Aesthetics and Protest, 8. Online. Retrieved December 1, 2022, from https://www.joaap.org/issue8/futurology.htm
   Google Scholar
• Farrugia, A., Fomiatti, R., Fraser, S., Moore, D., Edwards, M., Birbilis, E., & Treloar, C. (2022). Hepatitis C cure as a ‘gathering’: Attending to the social and material relations of hepatitis C treatment. Sociology of Health and Illness, 44(4-5), 830–847. https://doi.org/10.1111/1467-9566.13467
   PubMed Web of Science ®Google Scholar
• Fox, N. J., & Alldred, P. (2017). Sociology and the new materialism. Sage.
   Google Scholar
• Fraser, S. (2020). Doing ontopolitically-oriented research: Synthesising concepts from the ontological turn for alcohol and other drug research and other social sciences. International Journal of Drug Policy, 82, 102610. https://doi.org/10.1016/j.drugpo.2019.102610
   PubMed Web of Science ®Google Scholar
• Fraser, S., & Seear, K. (2011). Making disease, making citizens: The politics of hepatitis C. Ashgate.
   Google Scholar
• Goodyear, T., Brown, H., Browne, A. J., Hoong, P., Ti, L., & Knight, R. (2021). Stigma is where the harm comes from”: Exploring expectations and lived experiences of hepatitis C virus post-treatment trajectories among people who inject drugs. International Journal of Drug Policy, 96, 103238. https://doi.org/10.1016/j.drugpo.2021.103238
   PubMed Web of Science ®Google Scholar
• Grebely, J., Dore, G. J., Altice, F. L., Conway, B., Litwin, A. H., Norton, B. L., Dalgard, O., Gane, E. J., Shibolet, O., Nahass, R., Luetkemeyer, A. F., Peng, C.-Y., Iser, D., Gendrano, I. N., Kelly, M. M., Hwang, P., Asante-Appiah, E., Haber, B. A., Barr, E., … Platt, H. (2022). Reinfection and risk behaviors after treatment of hepatitis C virus infection in persons receiving opioid agonist therapy: A cohort study. Annals of Internal Medicine, 175(9), 1221–1229. https://doi.org/10.7326/M21-4119
   PubMed Web of Science ®Google Scholar
• Hajarizadeh, B., Cunningham, E. B., Valerio, H., Martinello, M., Law, M., Janjua, N. Z., Midgard, H., Dalgard, O., Dillon, J., Hickman, M., Bruneau, J., Dore, G. J., & Grebely, J. (2020). Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis. Journal of Hepatology, 72(4), 643–657. https://doi.org/10.1016/j.jhep.2019.11.012
   PubMed Web of Science ®Google Scholar
• Harm Reduction International. (2023). Global state of harm reduction 2023 update.
   Google Scholar
• Harris, M. (2017). Managing expense and expectation in a treatment revolution: Problematizing prioritisation through an exploration of hepatitis C treatment ‘benefit’. International Journal of Drug Policy, 47, 161–168. https://doi.org/10.1016/j.drugpo.2017.03.015
   PubMed Web of Science ®Google Scholar
• Kagan, D., Seear, K., Lenton, E., Farrugia, A., valentine, k., & Mulcahy, S. (2023). I’m not hep C free’: afterlives of hepatitis C in the era of cure. Medical Humanities.
   Google Scholar
• Latour, B. (2004). Why has critique run out of steam? From matters of fact to matters of concern. Critical Inquiry, 30(2), 225–248. https://doi.org/10.1086/421123
   Web of Science ®Google Scholar
• Law, J. (2004). After method: Mess in social science research. Routledge.
   Google Scholar
• Madden, A., Hopwood, M., Neale, J., & Treloar, C. (2018). Beyond cure: Patient reported outcomes of hepatitis C treatment among people who inject drugs in Australia. Harm Reduction Journal, 15(1), Article number 42, 1–8. https://doi.org/10.1186/s12954-018-0248-4
   PubMedGoogle Scholar
• Marshall, A. D., Rance, J., Grebely, J., & Treloar, C. (2022). ‘Not just one box that you tick off’ – deconstructing the hepatitis C care cascade in the interferon-free direct acting antiviral era from the client perspective. International Journal of Drug Policy, 102, 103610. https://doi.org/10.1016/j.drugpo.2022.103610
   PubMed Web of Science ®Google Scholar
• Mol, A. (2002). The body multiple: Ontology in medical practice. Duke University Press.
   Google Scholar
• Mol, A., & Law, J. (2002). Complexities: An introduction. In J. Law, A. Mol, B. Smith, & E. Weintraub (Eds.), Complexities: Social studies of knowledge practices (pp. 1–23). Duke University Press.
   Google Scholar
• Rance, J., & Treloar, C. (2023). The role of social science in hepatitis. In P. Liamputtong (Ed.), Handbook of social sciences and global public health (pp. 1–19). Springer International Publishing.
   Google Scholar
• Rhodes, T., & Lancaster, K. (2021). How to think with models and targets: Hepatitis C elimination as a numbering performance. International Journal of Drug Policy, 88, 102694. https://doi.org/10.1016/j.drugpo.2020.102694
   PubMed Web of Science ®Google Scholar
• Seear, K., Fraser, S., Farrugia, A., & Valentine, k. (2021). Beyond a ‘post-cure’ world: Sketches for a new futurology of hepatitis C. International Journal of Drug Policy, 94, 103042. https://doi.org/10.1016/j.drugpo.2020.103042
   PubMed Web of Science ®Google Scholar
• Valentine, K., & Seear, K. (2020). Commentary on Alex Stevens (2020) critical realism and the ‘ontological politics of drug policy’. The International Journal on Drug Policy, 84, 102879–102879. https://doi.org/10.1016/j.drugpo.2020.102879
   PubMed Web of Science ®Google Scholar
• World Health Organization. (2016). Global health sector strategy on viral hepatitis 2016-2021: Towards ending viral hepatitis.
   Google Scholar